Tower Research Capital (TRC)’s Aspira Women's Health Inc. Common Stock AWH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-4,130
Closed -$388 5696
2025
Q1
$388 Sell
4,130
-30
-0.7% -$9 ﹤0.01% 4909
2024
Q4
$2.93K Sell
4,160
-1,890
-31% -$1.54K ﹤0.01% 4744
2024
Q3
$4.9K Sell
6,050
-619
-9% -$688 ﹤0.01% 4383
2024
Q2
$9.94K Buy
6,669
+3,223
+94% +$8.44K ﹤0.01% 4194
2024
Q1
$10.7K Buy
3,446
+1,582
+85% +$6.84K ﹤0.01% 3666
2023
Q4
$7.61K Buy
1,864
+1,444
+344% +$5.89K ﹤0.01% 4600
2023
Q3
$2.25K Sell
420
-2,926
-87% -$11K ﹤0.01% 5182
2023
Q2
$11.1K Buy
3,346
+1,921
+135% +$8.09K ﹤0.01% 4017
2023
Q1
$8K Buy
1,425
+1,422
+47,400% +$9.65K ﹤0.01% 4692
2022
Q4
$0 Sell
3
-1,659
-100% -$9.06K ﹤0.01% 6557
2022
Q3
$9K Buy
1,662
+1,416
+576% +$15.2K ﹤0.01% 4724
2022
Q2
$2K Sell
246
-2,220
-90% -$22.5K ﹤0.01% 5638
2022
Q1
$38K Sell
2,466
-422
-15% -$7.31K ﹤0.01% 2953
2021
Q4
$77K Buy
2,888
+2,430
+531% +$92.2K ﹤0.01% 2421
2021
Q3
$22K Buy
458
+81
+21% +$5.01K ﹤0.01% 3651
2021
Q2
$31K Sell
377
-36
-9% -$3.09K ﹤0.01% 3470
2021
Q1
$42K Sell
413
-6
-1% -$659 ﹤0.01% 3279
2020
Q4
$42K Sell
419
-3,023
-88% -$202K ﹤0.01% 3286
2020
Q3
$159K Buy
3,442
+3,133
+1,014% +$161K ﹤0.01% 2772
2020
Q2
$18K Buy
+309
New +$20.6K ﹤0.01% 3746

Other funds holding AWH

Tower Research Capital (TRC)'s AWH Position: Q2 2025 in Review

Tower Research Capital (TRC) sold out of Aspira Women's Health Inc. Common Stock (AWH) in Q2 2025, closing a stake of 4,130 shares — an estimated $388 sold.

Tower Research Capital (TRC) first reported a position in AWH in Q2 2020 and held it in 20 quarters. The position peaked at $159K in Q3 2020. 2 funds tracked by Wall St. Rank hold AWH as of Q2 2025.

  • Tower Research Capital (TRC) reported no remaining Aspira Women's Health Inc. Common Stock position as of Q2 2025 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 4,130 Aspira Women's Health Inc. Common Stock shares in Q2 2025, an estimated $388.
  • Tower Research Capital (TRC) first reported a position in Aspira Women's Health Inc. Common Stock in Q2 2020 and held it in 20 quarters.
  • Tower Research Capital (TRC)'s Aspira Women's Health Inc. Common Stock position peaked at $159K in Q3 2020.
  • 2 funds tracked by Wall St. Rank held Aspira Women's Health Inc. Common Stock as of Q2 2025.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2025, filed 15 Aug 2025.